| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 12/16/1992 | EP0518676A2 Cyclic renin inhibitors |
| 12/16/1992 | EP0518675A2 Cyclic renin inhibitors |
| 12/16/1992 | EP0518672A2 Cyclic renin inhibitors |
| 12/16/1992 | EP0518391A1 CRF analogs |
| 12/16/1992 | EP0517913A1 Inhibitions of endothelin formation |
| 12/16/1992 | CN1067057A Process for preparing unsaturated 17 -substituted 3-carboxysteroids |
| 12/12/1992 | CA2070983A1 Cyclic renin inhibitors |
| 12/12/1992 | CA2070978A1 Cyclic renin inhibitors |
| 12/12/1992 | CA2070972A1 Cyclic renin inhibitors |
| 12/10/1992 | WO1992021695A1 Vitamin d derivatives comprising a lateral chain expoxide group |
| 12/10/1992 | WO1992017025A3 GnRH analogs |
| 12/10/1992 | CA2110158A1 Vitamin d derivatives comprising a lateral chain expoxide group |
| 12/09/1992 | EP0517047A1 Unsaturated 17beta-substituted 3-carboxy steroids |
| 12/02/1992 | EP0516530A1 New 6-substituted steroids with a thioethyl group in the 10 position, a process for their preparation and intermediates therefor, their use as medicines and pharmaceutical compositions thereof |
| 12/02/1992 | EP0516392A2 Naphthyridine derivatives as angiotensin II inhibitors |
| 12/01/1992 | CA2068946A1 Heterocyclic derivatives |
| 11/28/1992 | CA2069570A1 6-substituted steroid products containing a thioethyl group in position 10; process for preparing the same and intermediate compounds thereof; their use as therapeutic agents and pharmaceutical products containing them |
| 11/26/1992 | WO1992021029A1 Selecting ligand agonists and antagonists |
| 11/26/1992 | WO1992020342A1 Novel composition of angiotensin-ii receptor antagonists and calcium channel blockers |
| 11/26/1992 | WO1992020331A1 Receptor ligands |
| 11/26/1992 | CA2103276A1 Novel composition of angiotensin-ii receptor antagonists and calcium channel blockers |
| 11/25/1992 | WO1992020700A1 UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS |
| 11/25/1992 | CA2087953A1 Unsaturated 17.beta. -substituted 3-carboxy steroids |
| 11/24/1992 | US5166201 2β,19-ethylene bridged steroids as aromatase inhibitors |
| 11/24/1992 | US5166199 11β-aryl-16α,17α-cyclohexano-estra-4,9-dienes |
| 11/18/1992 | CN1066271A 14 beta-h-,14-and 15-ene-11 beta-aryl-4-estrene |
| 11/17/1992 | US5164368 Treatment for osteoporosis using growth hormone releasing factor (grf) in combination with parathyroid hormone (pth) |
| 11/12/1992 | WO1992019651A1 Luteinizing hormone releasing hormone antagonist peptides |
| 11/11/1992 | EP0512042A1 Glp-1 analogs useful for diabetes treatment |
| 11/10/1992 | US5162312 11β-substituted 16α, 17α-methylene-estra-4,9-dien-3-ones |
| 11/10/1992 | US5162305 Polypeptide derivatives |
| 10/28/1992 | EP0510167A1 Novel steroidal organic substance crystallization method and compounds thereby obtained. |
| 10/28/1992 | EP0510080A1 Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use |
| 10/28/1992 | EP0290496B1 Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery |
| 10/21/1992 | EP0509317A2 Use of droloxifene in the treatment of bone diseases |
| 10/20/1992 | US5156957 Transformed mammalian cell containing an expression vector which is capable of producing a heterodimeric human fertility hormone coded by a distinct RNA |
| 10/15/1992 | WO1992017602A1 Parathyroid hormone receptor and dna encoding same |
| 10/13/1992 | US5155250 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents |
| 10/13/1992 | US5155101 Cholecystokinin antagonist; preventing emesis or pancreatitis |
| 10/12/1992 | WO1992021700A1 Novel calcitonin, and production and use thereof |
| 10/07/1992 | EP0506890A1 Recombinant thyrotropin receptor |
| 10/07/1992 | CN1065070A 6,7-modified 11beta-aryl-4-estrene |
| 10/01/1992 | WO1992017025A2 GnRH ANALOGS |
| 10/01/1992 | WO1992016620A1 Human follicle stimulating hormone receptor |
| 10/01/1992 | WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/30/1992 | EP0505893A1 Imidazopyridines |
| 09/29/1992 | CA1308095C 11.beta.-ARYLESTRADINENES, THE PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME |
| 09/23/1992 | EP0504403A1 Topical therapeutic preparation |
| 09/22/1992 | US5149696 Antiestrogens |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/09/1992 | EP0473716A4 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 09/08/1992 | CA1307374C Peptides containing an aliphatic-aromatic ketone side chain |
| 09/07/1992 | WO1992015681A1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN |
| 09/07/1992 | CA2105572A1 Human galanin, cdna clones encoding human galanin and a method of producing human galanin |
| 09/03/1992 | WO1992014719A1 Thiazolidine-2,4-dione derivative, salt thereof, and production of the same |
| 09/02/1992 | EP0401243B1 Medicinal preparations characterized by a combination of cytostatic agents, hormonal therapeutic agents and phosphone derivatives |
| 08/26/1992 | EP0500297A1 Substituted pyridinones and pyrimidinones as angiotensin II antagonists |
| 08/18/1992 | US5140009 Stable against proteolytic enzymes; anticarcinogenic agents; urogenital disorders |
| 08/17/1992 | WO1992014714A1 Substituted pyridinones and pyrimidinones as angiotensin ii antagonists |
| 08/12/1992 | EP0497915A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE. |
| 08/11/1992 | US5137901 For binding 5-HT 1 receptors; treating central nervous system disorders |
| 08/04/1992 | US5135937 Aromatase inhibitors |
| 07/29/1992 | CN1063102A Phenylimidazolidines, process for their preparation, their use as medicaments and pharmaceutical compositions containing them |
| 07/28/1992 | US5134164 Use of 3-guanidinopropionic acid in the treatment of excess adiposity |
| 07/23/1992 | WO1992012170A1 Inhibitions of endothelin formation |
| 07/21/1992 | US5132400 Peptides containing a (1-amino-2-hydroxy-2-heterocyclic)ethyl moiety |
| 07/21/1992 | US5132324 Use of 3-guanidinopropionic acid in the treatment of non-insulin dependent diabetes mellitus (niddm) |
| 07/15/1992 | EP0494819A1 Phenylimidazolidines, their process for fabrication, their application as medicaments and the pharmaceutical compositions containing them |
| 07/14/1992 | US5130318 Hypotensive agents and for treatment of congestive heart failure |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/07/1992 | US5128242 Hormone release |
| 06/30/1992 | US5126324 Method of enhancing growth in patients using combination therapy |
| 06/25/1992 | DE4042007A1 6,7-modifizierte-11(beta)-aryl-4-estrene 6,7-modified-11 (beta) -Aryl-4-Estrenes |
| 06/25/1992 | DE4042005A1 D-homo-(16-en)-11(beta)-aryl-4-estrene D-homo (16-s) -11 (beta) aryl-4-Estrenes |
| 06/25/1992 | DE4042004A1 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene 14 (beta) -h, 14 u. 15-en-11 (beta) aryl-4-Estrenes |
| 06/24/1992 | EP0490947A1 Prodrug derivatives of thyrotropin-releasing hormone (trh) |
| 06/23/1992 | WO1992011279A1 D-HOMO-(16-EN)-11β-ARYL-4-ESTRENES, PROCESS FOR PRODUCING THEM AND THEIR USE AS MEDICAMENTS |
| 06/23/1992 | WO1992011278A1 14β-H-, 14- AND 15-EN-11β-aryl-4-ESTRENES |
| 06/23/1992 | WO1992011277A1 6,7-MODIFIED 11β-ARYL-4-ESTRENES |
| 06/23/1992 | CA2099018A1 6,7-modified 11.beta.-aryl-4-estrenes |
| 06/23/1992 | CA2099016A1 14.beta.-h-, 14- and 15-en-11.beta.-aryl-4-estrenes |
| 06/17/1992 | EP0490816A2 Fluoro-compounds |
| 06/17/1992 | EP0490561A2 Nutrition |
| 06/17/1992 | EP0490249A1 Process for the enzymatic preparation of GRF(1-44)NH2 |
| 06/17/1992 | CN1061974A 2beta, 19-ethylene bridged steroids as aromatase inhibitors |
| 06/16/1992 | US5122610 Renin inhibitor intermediates |
| 06/11/1992 | WO1992009304A1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
| 06/11/1992 | CA2057269A1 Process for the enzymatic preparation of grf(1-44)nh2 |
| 06/10/1992 | EP0489058A1 Cystic fibrosis gene |
| 06/08/1992 | CA2056957A1 Nutrition |
| 06/04/1992 | DE4038128A1 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate 8-ene-19, 11 (beta) -ueberbrueckte steroids, their production and pharmaceutical compositions containing them |
| 06/03/1992 | EP0488383A1 2-beta,19-ethylene bridged steroids as aromatase inhibitors |
| 06/03/1992 | CN1061606A Polypeptide compounds having growth hormone releasing activity |
| 06/02/1992 | CA1302650C Gnrh antagonists viii |
| 05/29/1992 | WO1992008730A1 Novel steroidal organic substance crystallization method and compounds thereby obtained |
| 05/28/1992 | WO1992009618A1 8-ENE-19, 11β-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM |
| 05/28/1992 | CA2097079A1 8-ene-19, 11.bet.beta.-bridged steroids, their preparation and pharma ceutical formulations containing them |
| 05/27/1992 | EP0487512A1 Production of heterodimeric human fertility hormones |
| 05/27/1992 | EP0487252A1 Quinoline and 1,5-Naphthyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| 05/20/1992 | EP0485392A1 Androgen derivatives for use in the inhibition of sex steroid activity |